FULL EVENT GUIDE

Browse the Event Guide to Discover:

18+

industry leading speakers from the likes of NeuroTherapia, Roche, RespireRX Pharmaceuticals, GB Sciences, Neuropathix, and Artelo Biosciences

6

hours of intimate pre-conference workshop discussions, delving into the potential of CB1-targeting therapies for obesity and diabetes treatment and navigating the complex regulatory landscape for cannabinoid research

8+

hours of dedicated networking time across speed networking, roundtable discussions, panels and more

1

scientific poster session, giving you the opportunity to display your own research to this diverse audience of discovery, preclinical and clinical cannabinoid and ECS-targeting drug development experts

CB1 Cover